Metabolic flexibility, baseline GLP-1 receptor expression, and genetic variation in appetite-signaling pathways influence how quickly the medication engages weight loss mechanisms
Ozempic is not approved for weight loss, but liraglutide is
These are normal metabolic adaptation events, not medication failure
Most people need a plan to maintain results. Long-term success comes from a combination of: Medication (when needed) Nutrition habits Muscle-preserving exercise Metabolic follow-ups Lifestyle coaching Patients who stop suddenly and stop these supportive habits typically regain the most weight
Its also not ideal for someone hoping for fast results without making small habit changes, since long-term progress still comes from steady, consistent routines
Tirzepatide and semaglutide are appropriate for patients who: Have at least 20 pounds of fat to lose Struggle with cravings, overeating, or stalled progress despite trying on their own Have signs of insulin resistance, metabolic syndrome, or hormone-related weight gain Want a physician-led, sustainable plan that protects metabolism, muscle, and appearance Who Should Not Use Tirzepatide (Zepbound) or Semaglutide (Wegovy)